Ayotte Statement on New FDA Safety Warning Labels

Statement

Today, U.S. Senator Kelly Ayotte released a statement regarding the U.S. Food and Drug Administration's (FDA) announcement that they will require the strongest level of safety warning labels on nearly 400 products about serious health risks associated with using certain opioids and benzodiazepines.

"Today's announcement from FDA is a step forward, and it acknowledges the issues surrounding safe pain management and responsible prescribing practices. According to FDA data, overdose deaths caused by using certain kinds of prescription opioids in combination with drugs commonly prescribed to treat neurological or psychological conditions almost tripled from 2004 to 2011. While prescription opioids and benzodiazepines serve necessary purposes for many people, these labels are designed to help avoid serious risks, including overdose and even death. I appreciate FDA's attention to this serious matter, and continue to urge them to work with stakeholders so the agency can be a better partner in preventing opioid abuse."

Source